Peptide Sciences Shut Down — March 6, 2026: Facts and Successor Checklist | Artemis Labs
Peptide Sciences Shut Down: The March 6, 2026 Closure and a Successor Checklist
Published August 21, 2026 · Artemis Labs
Peptide Sciences shut down on March 6, 2026, announcing its closure, halting all order processing, and taking its site offline shortly after. The company’s closure notice states that any further sales under its brand are fraudulent — which means, by the company’s own words, every site now selling under that name is not Peptide Sciences. Here is the dated record and what to do next.
Key findings
- The closure was announced March 6, 2026. Order processing stopped, and the site went offline shortly after. The company gave no detailed explanation.
- The fraud warning came from the company itself. The closure notice states that any further sales under the Peptide Sciences brand are fraudulent — the single test that settles every “is this site real” question.
- Lookalike sites are a documented pattern, not a hypothetical. Unaffiliated sites reusing Peptide Sciences branding have appeared since the shutdown, and a similarly named domain surfaced after Paradigm Peptides went down in 2024.
What happened on March 6, 2026
Peptide Sciences announced on March 6, 2026 that it was closing. All order processing halted. The site went offline shortly after. At the time, industry traffic estimates placed Peptide Sciences in a roughly $7.4-million-per-month revenue class — the largest US research-peptide vendor.
Peptide Sciences offered no detailed explanation. Industry coverage noted the backdrop — an FDA enforcement wave across 2024–2026, GLP-1 litigation pressure, and import restrictions — but the company itself did not state a cause, and this page does not assert one.
The company’s own warning about its brand
Peptide Sciences’ closure notice states that any further sales under its brand are fraudulent. That sentence is the operative fact of the shutdown’s aftermath. It is not an accusation made by a competitor or a regulator — it is the company describing what any post-closure use of its own name means.
Unaffiliated sites reusing the Peptide Sciences branding have appeared since. The notice makes evaluating them simple: a site processing orders under the Peptide Sciences name after March 6, 2026 is, per the company’s own statement, not the company.
How to spot clone and lookalike sites
Clone sites trade on a dead brand’s residual search demand and customer trust. The pattern has precedent in this market: after Paradigm Peptides’ site went down in March 2024, a similarly named domain (paradigmpeptides.is) appeared — itself stating it had no affiliation with the original company. Red flags worth checking, in order:
- Any order-taking under the Peptide Sciences name. The closure notice makes this the defining test; no further verification is needed.
- A familiar logo on an unfamiliar domain. Brand assets are trivial to copy; domain history is not.
- No named, checkable testing documentation. A site reusing a brand rarely reproduces the analytical paper trail behind it.
- Pressure tactics a research vendor would not use — countdown timers, claimed “final stock” of a company that announced it stopped selling.
A successor-evaluation checklist
Former Peptide Sciences customers do not need a leap of faith; they need a sequence of checks that works on any vendor. Run these in order:
- Confirm the vendor is who it claims to be. Match the operating name, the domain, and the published contact details before reading anything else.
- Ask who performs the analytical testing. Third-party HPLC (purity) plus MS (identity) is the baseline; in-house-only testing leaves the vendor grading its own work.
- Expect a Certificate of Analysis with the order itself — not just a specimen on a marketing page. The guide to reading a Certificate of Analysis shows what a complete document contains.
- Follow the citations. Product pages should trace claims to PubMed or DOI links a reader can open. Uncited claims are a register choice, and it is not the research register.
- Look for counter-evidence disclosure. A vendor that publishes findings unfavorable to its own catalog has shown you its standard.
- Check what else is in the cart. FDA’s March 2026 warning letters cite administration supplies offered in the same cart as evidence that products were intended as drugs for human use.
- Read the policies before ordering. Shipping, refund, privacy, and research-use terms should be published, not promised.
The full scoring version of this sequence is in the supplier-evaluation checklist for research-peptide vendors, and the comparison framework built on it — including how Artemis Labs measures against each criterion — is in Peptide Sciences alternatives: a verification-first framework. Artemis Labs publishes its research literature index at the Artemis Labs research library; everything it supplies is for laboratory research use only.
The wider enforcement picture
The Peptide Sciences closure did not happen in a quiet market. FDA issued warning letters to four research-peptide sellers on December 10, 2024, and to seven more sites in a batch dated March 31, 2026 (posted April 7, 2026). More than one hundred FDA warning letters have gone to peptide and research-use-only sellers since September 2025. The dated, event-by-event record — who closed, who was raided, who was sentenced — is maintained on the peptide vendor closures 2025-2026 hub.
Frequently asked questions
When did Peptide Sciences shut down?
March 6, 2026 — the company announced its closure, halted all order processing, and its site went offline shortly after.
Is any site still selling under the Peptide Sciences name legitimate?
No, per the company’s own closure notice, which states that any further sales under its brand are fraudulent. That statement predates and settles every later claim by any site using the name.
Why did Peptide Sciences shut down?
The company gave no detailed explanation. Industry coverage cited context — FDA enforcement across 2024–2026, GLP-1 litigation pressure, import restrictions — but context is not a stated cause, and no cause should be asserted as fact.
What should former Peptide Sciences customers do now?
Run the successor checklist above against any candidate vendor: confirm identity, verify third-party HPLC and MS testing, expect a per-order COA, follow the citations, check for counter-evidence disclosure, confirm no administration supplies, and read the published policies.
References
- Peptides Explorer — “Peptide Sciences Shut Down.” peptidesexplorer.com/blog/peptide-sciences-shut-down
- BioStrata Research — “Did Peptide Sciences Shut Down?” biostrataresearch.com
- CBS News — Paradigm Peptides sentencing coverage (lookalike-domain precedent). cbsnews.com
- US FDA — Warning Letters database (December 10, 2024 and March 31, 2026 batches). fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters
